Patents by Inventor Klaus Hansen

Klaus Hansen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method of treating diseases that respond to therapy by dopamine or dopamine agonists
    Patent number: 9108900
    Abstract: The invention relates to a medicament containing (S)-2-N-propylamino-5-hydroxytetralin, the salts or prodrugs thereof. As a D3 agonist, (S)-2-N-propylamino-5-hydroxytetralin is suitable particularly for the treatment of dopa-sensitive movement disorders.
    Type: Grant
    Filed: October 25, 2013
    Date of Patent: August 18, 2015
    Assignee: UCB PHARMA GMBH
    Inventors: Dieter Scheller, Klaus Hansen
  • METHOD OF TREATING DISEASES THAT RESPOND TO THERAPY BY DOPAMINE OR DOPAMINE AGONISTS
    Publication number: 20140051768
    Abstract: The invention relates to a medicament containing (S)-2-N-propylamino-5-hydroxytetralin, the salts or prodrugs thereof. As a D3 agonist, (S)-2-N-propylamino-5-hydroxytetralin is suitable particularly for the treatment of dopa-sensitive movement disorders.
    Type: Application
    Filed: October 25, 2013
    Publication date: February 20, 2014
    Applicant: UCB Pharma GmbH
    Inventors: Dieter Scheller, Klaus Hansen
  • (S)-2-N-propylamino-5-hydroxytetralin as a D3-agonist
    Patent number: 8609641
    Abstract: The invention relates to a medicament containing (S)-2-N-propylamino-5-hydroxytetralin, the salts or prodrugs thereof. As a D3 agonist, (S)-2-N-propylamino-5-hydroxytetralin is suitable particularly for the treatment of dopa-sensitive movement disorders.
    Type: Grant
    Filed: December 13, 2004
    Date of Patent: December 17, 2013
    Assignee: UCB Pharma GmbH
    Inventors: Dieter Scheller, Klaus Hansen
  • ENTACAPONE-DERIVATIVES
    Publication number: 20080103191
    Abstract: Pharmaceutical composition comprising one or more entacapone derivatives and one or more pharmaceutically acceptable carriers, a process for producing the pharmaceutical composition, specific entacapone derivatives, a process for the preparation of entacapone derivatives, and the use of the entacapone derivatives for the preparation of a medicament.
    Type: Application
    Filed: June 14, 2007
    Publication date: May 1, 2008
    Inventors: Klaus Hansen, Robert Kraemer, Thomas Lauterbach, Dirk Schmidt, Fritz Paar, Petra Pfeiffer, Detlef Geffken, Wolfgang Thimann, Katharina Wehner
  • Building System
    Publication number: 20080040986
    Abstract: A building system is disclosed having building constituent assemblies including wall panels (10), a flooring assembly (60), a ceiling assembly (94) and a roofing assembly (96). Each of the building constituent assemblies includes a supporting structure (12, 62) and a covering member (14, 64). The supporting structure (12, 62) includes a supporting member (20, 66) which has a corrugated first side portion (30, 74) and second side portion (34, 76). The side portions of adjacent supporting structures (12, 62) overlay each other and interlock the adjacent constituent assemblies together.
    Type: Application
    Filed: June 14, 2005
    Publication date: February 21, 2008
    Inventors: Tyge Madsen, Klaus Hansen
  • (S)-2-N-Propylamino-5-Hydroxytetralin As A D3-Agonist
    Publication number: 20070197480
    Abstract: The invention relates to a medicament containing (S)-2-N-propylamino-5-hydroxytetralin, the salts or prodrugs thereof. As a D3 agonist, (S)-2-N-propylamino-5-hydroxytetralin is suitable particularly for the treatment of dopa-sensitive movement disorders.
    Type: Application
    Filed: December 13, 2004
    Publication date: August 23, 2007
    Applicant: SRZ Properties, Inc.
    Inventors: Dieter Scheller, Klaus Hansen
  • Foam flotation protein separatior
    Patent number: 5800704
    Abstract: In order to reduce the noise made by a foam flotation separator working on the dispersion apparatus principle and maximise the air supply, the foam flotation separator is designed so as to comprise a dispersion pump (2) which draws in water and a gas such as air and/or ozone, a reaction chamber connected on the delivery side, a collector (5) on the upper end of the reaction chamber (4) and an expanded section (15) at the lower, outlet end of the reaction chamber (4).
    Type: Grant
    Filed: November 8, 1996
    Date of Patent: September 1, 1998
    Assignee: AquaMedic Anlagenbau GmbH
    Inventor: Klaus Hansen